Total Number of Communication Reports: 4
Monthly communication reports in the last 6 months: 0
End date of the last completed financial year: 2019-12-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
US Department of Defense Peer Reviewed Medical Research Program | $2,800,000.00 | Yes |
Address:
180 John Street
Suite 305
Toronto, ON M5T 1X5
Canada
Telephone number:
917-597-4164
Douglas A. Hamilton, Chief Executive Officer
Vasomune Therapeutics Inc. is not a subsidiary of any other parent companies.
Vasomune Therapeutics Inc. is not a coalition.
The activities of Vasomune Therapeutics Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Danya Vered | Public offices held
Firm: StrategyCorp Inc